Cappellari, Manuel; Seiffge, David J; Koga, Masatoshi; Paciaroni, Maurizio; Forlivesi, Stefano; Turcato, Gianni; Bovi, Paolo; Yoshimura, Sohei; Tanaka, Kanta; Shiozawa, Masayuki; Yoshimoto, Takeshi; Miwa, Kaori; Takagi, Masahito; Inoue, Manabu; Yamagami, Hiroshi; Caso, Valeria; Tsivgoulis, Georgios; Venti, Michele; Acciarresi, Monica; Alberti, Andrea; ... (2020). A nomogram to predict unfavourable outcome in patients receiving oral anticoagulants for atrial fibrillation after stroke. European stroke journal, 5(4), pp. 384-393. Sage 10.1177/2396987320945840
Text
Cappellari__2021__A_monogram_to_predict_unfavourable_outcome.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (706kB) |
Introduction
It is unknown whether the type of treatment (direct oral anticoagulant versus vitamin K antagonist) and the time of treatment introduction (early versus late) may affect the functional outcome in stroke patients with atrial fibrillation. We aimed to develop and validate a nomogram model including direct oral anticoagulant/vitamin K antagonist and early/late oral anticoagulant introduction for predicting the probability of unfavourable outcome after stroke in atrial fibrillation-patients.
Patients and Methods
We conducted an individual patient data analysis of four prospective studies. Unfavourable functional outcome was defined as three-month modified Rankin Scale score 3 -6. To generate the nomogram, five independent predictors including age (<65 years, reference; 65--79; or 80), National Institutes of Health Stroke Scale score (0--5 points, reference; 6--15; 16--25; or >25), acute revascularisation treatments (yes, reference, or no), direct oral anticoagulant (reference) or vitamin K antagonist, and early (7 days, reference) or late (8--30) anticoagulant introduction entered into a final logistic regression model. The discriminative performance of the model was assessed by using the area under the receiver operating characteristic curve.
Results
A total of 2102 patients with complete data for generating the nomogram was randomly dichotomised into training (n = 1553) and test (n = 549) sets. The area under the receiver operating characteristic curve was 0.822 (95% confidence interval, CI: 0.800--0.844) in the training set and 0.803 (95% CI: 0.764--0.842) in the test set. The model was adequately calibrated (9.852; p = 0.276 for the Hosmer--Lemeshow test).
Discussion and Conclusion
Our nomogram is the first model including type of oral anticoagulant and time of treatment introduction to predict the probability of three-month unfavourable outcome in a large multicentre cohort of stroke patients with atrial fibrillation.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology |
UniBE Contributor: |
Seiffge, David Julian |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2396-9873 |
Publisher: |
Sage |
Language: |
English |
Submitter: |
Chantal Kottler |
Date Deposited: |
06 Jul 2021 17:59 |
Last Modified: |
05 Dec 2022 15:51 |
Publisher DOI: |
10.1177/2396987320945840 |
PubMed ID: |
33598557 |
Uncontrolled Keywords: |
Stroke atrial fibrillation direct oral anticoagulant nomogram outcome vitamin K antagonist |
BORIS DOI: |
10.48350/157360 |
URI: |
https://boris.unibe.ch/id/eprint/157360 |